Conditions: Pain, Post-operative
Keywords: Abdominoplasty Pain Analgesia N1539 Phase 3
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 219
Healthy volunteers: no

Brief summary:
The primary objective of this study is to evaluate the analgesic efficacy of N1539 in subjects with acute moderate to severe pain following abdominoplasty surgery.

Detailed description:

Arms:
arm 1: N1539 (Intravenous meloxicam) 30mg every 24 hours for up to 3 doses. arm 2: IV Placebo every 24 hours for up to 3 doses.

Interventions: intervention 1: N1539 intervention 2: Intravenous Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: